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consumers reports intolerance or allergy-like symptoms after drinking
wine.1 Chitosan is a linear polysaccharide and the product of the
deacetylation of chitin, the main component of the cell walls of some
fungi; the exoskeletons of arthropods, such as crustaceans and insects;
and the beaks of cephalopods.2 It alsomay be used inwine processing.
Concerns have been raised that wines processed with chitosan
could trigger reactions in patients with seafood allergy. Neverthe-
less, biological plausibility is scarce. Major allergens involved in
shrimp allergy are muscle proteins, although someminor allergens,
such as arginine kinase, which was found to be clinically relevant,
have been found in shrimp shells.3 The chitosan isolation procedure
is expected to remove all proteins and contaminants. Fear of
ingesting a shellfish-derived product may lead to unnecessary
avoidance of wine produced with chitosan films.
Recently, anaphylactic reaction to a-1,3-galactose has been iden-
tified.4Chitosan isstructurallydifferent froma-galbecause it is a linear
cationic (1/4)-2-amino-2-deoxy-b-D-glucan. There is only one case
report of an immediate anaphylactic reactionwith health food (fungi-
derived) chitosan ingestion, with documented sensitization by skin
prick tests.5 Shrimp-derived chitosanhas been given the classification
of generally recognized as safe (GRAS) by the US Food and Drug
Administration (FDA) in 2012.6 Moreover, evidence supporting this
classification is limited by the lack of inclusion of individuals with
shrimp allergy and the absence of food challenges. To our knowledge,
no previous studies have evaluated the safety of chitosan as a food
additive in shrimp allergic patients. Therefore, we aimed to assess the
safety of chitosan processed wine in shrimp allergic patients.
This double-blind, placebo-controlled trial was registered at
ClinicalTrials.gov (NCT02151279). Adults (18e65 years) with evi-
dence of IgE-mediated sensitization to shrimp and a history of
anaphylaxis to shrimp and/or a positive oral challenge result to
shrimp were selected. Participants were recruited from the food
allergy unit of an allergy department of a university hospital.
A control group of 6 healthy, nonatopic, nonefood allergic in-
dividuals were invited to participate. All individuals included in this
study were regular consumers of wine and were asked to avoid
alcohol ingestion for at least 3 days before the challenge. Nineteen
individuals were enrolled, including 13 with anaphylaxis to shrimp
(Table 1) and 6 healthy controls.
Skin prick-to-prick testswithwineswere performed, as well as a
double-blind, placebo-controlled challenge with both wines (with
and without chitosan) in all participants. The challenges were per-
formed on the same day, separated by at least 2 hours. Successive
increasing doses were administered in 4 steps with 15-minute in-
tervals up to a total of 100mLof eachwineduring each challenge.On
completion, participants were observed for 2 hours, and, in case of
any delayed reaction, participants were instructed to contact theDisclosures: Authors have nothing to disclose.
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Universidade do Porto, approved the study, and signed informed
consent was obtained from all participants.
The wines processed with chitosan-based films (active chal-
lenge) and the wines conserved with sulfur dioxide were indistin-
guishable in color, smell, or taste, at least for nonsommelier study
participants. After fermentation, instead of using sulfur dioxide for
wine preservation, chitosan films cross-linked with genipin were
immersed in the wine in a proportion of 60 cm2/L of wine.7
A positive skin test result was defined as the presence after 15
minutes of a wheal mean diameter of 3 mm or larger than that eli-
cited by the negative control accompanied by erythema. Positive
(histamine, 10 mg/mL) and negative (saline solution) controls were
also included. During challenges, occultation was performed by an
ombudsman, and each wine was placed in identified equal
containers. The randomization codes were packed in sealed, non-
transparent envelopes that remained closed until the end of the
study. Only 1 shrimp allergic participant had positive skin prick test
result to bothwines. All the other participants had negative skin test
results to both wines. None of the 13 shrimp allergic patients and
none of the control participants had immediate- or late-phase re-
actions to any of thewines. No subjective symptomswere reported;
therefore, no medical intervention was necessary.
Our study found thatwine processedwith chitosan-basedfilms as
a preservative agent may be safely consumed by shrimp allergic in-
dividuals. We selected patients with severe shrimp allergy, and all of
them tolerated this wine; consequently, it is unlikely that individuals
with a similar history of allergic reactions or mild allergic reactions
would react to this type of wine. To our knowledge, this is the first
study to evaluate the safety of seafood-derived chitosan in shrimp
allergic patients, using double-blind, placebo-controlled challenges.
We also found that the isolated use of skin testing is insufficient for
diagnosis. One patient had positive skin test results to bothwines. Skin
prick testing with nonstandardized matrices, such as wine, can be
associatedwith nonspecific testing, as previously described for orange
juice.8 However, there was no clinical significance of the positive skin
test results because the oral challenge result was negative. Another
strength is that our sample only included patients with anaphylaxis to
shrimp. This decreases the concern that reactions may occur only in a
dose-dependent manner and reinforces the statement of the FDA that
chitosan is GRAS, even in patients with severe shrimp allergy.
Chitosan is considered to be a nontoxic and nonallergenic
material that is suitable for use in medical and pharmaceutical
applications.9 Furthermore, it has been tested as topic bandages in
shellfish allergic patients, and no adverse reactions were
reported.10 Our study contributes to overcome the paucity of data
regarding the patients with shrimp allergy. Furthermore, evidence
that sulfite-free chitosan-treated wines are also a safe alternative
for shrimp allergic patients broadens its use.lsevier Inc. All rights reserved.
Table 1
Demographic and clinical characteristics of the shrimp allergic patients
Characteristics N (%)
Age (years), median IQR 34, [26e42]
Female 10 (77)
House dust mite sensitization 11 (85)
Atopic diseases 13 (100)
Allergic rhinitis 13 (100)
Asthma 5 (38.5)
Atopic eczema 2 (15.4)
Symptoms
Anaphylaxis 13 (100)
Cutaneous 13 (100)
Othera 13 (100)
Time (years) since last shrimp allergic reaction, median IQR 2, [1e4]
Wheal size of skin prick test with shrimp extract, mean (sd) 6.1 (2.1)
Wheal size of skin prick-prick test, mean (sd) 9.4 (7.5)
Shrimp sIgE (kU/L), mean (sd) 12.5 (31.4)
Abbreviations: IQR, interquartile range; sd, standard deviation; sIgE, specific IgE.
Data is presented as number and percentage, except when otherwise stated.
aDyspnea, throat tightness, oropharyngeal pruritus, hypotension, vomit, abdominal
pain and diarrhea.
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Nonetheless, all the participants hadprevious historyof anaphylaxis
to shrimp and other seafood, and all of them had atopic comorbid-
ities, making them a particularly high-risk group. In conclusion, this
study indicates that wine treatedwith chitosan is unlikely to trigger
allergic reactions in patients with shrimp allergy.
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